This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!
Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log in
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Apr 3:4:38.
doi: 10.3389/fvets.2017.00038. eCollection 2017.

Cost Description and Comparative Cost Efficiency of Post-Exposure Prophylaxis and Canine Mass Vaccination against Rabies in N'Djamena, Chad

Affiliations

Cost Description and Comparative Cost Efficiency of Post-Exposure Prophylaxis and Canine Mass Vaccination against Rabies in N'Djamena, Chad

Rolande Mindekem et al. Front Vet Sci. .

Abstract

Rabies claims approximately 59,000 human lives annually and is a potential risk to 3.3 billion people in over 100 countries worldwide. Despite being fatal in almost 100% of cases, human rabies can be prevented by vaccinating dogs, the most common vector, and the timely administration of post-exposure prophylaxis (PEP) to exposed victims. For the control and prevention of human rabies in N'Djamena, the capital city of Chad, a free mass vaccination campaign for dogs was organized in 2012 and 2013. The campaigns were monitored by parallel studies on the incidence of canine rabies based on diagnostic testing of suspect animals and the incidence of human bite exposure recorded at selected health facilities. Based on the cost description of the campaign and the need for PEP registered in health centers, three cost scenarios were compared: cumulative cost-efficiency of (1) PEP alone, (2) dog mass vaccination and PEP, (3) dog mass vaccination, PEP, and maximal communication between human health and veterinary workers (One Health communication). Assuming ideal One Health communication, the cumulative prospective cost of dog vaccination and PEP break even with the cumulative prospective cost of PEP alone in the 10th year from the start of the calculation (2012). The cost efficiency expressed in cost per human exposure averted is much higher with canine vaccination and One Health communication than with PEP alone. As shown in other studies, our cost-effectiveness analysis highlights that canine vaccination is financially the best option for animal rabies control and rabies prevention in humans. This study also provides evidence of the beneficial effect of One Health communication. Only with close communication between the human and animal health sectors will the decrease in animal rabies incidence be translated into a decline for PEP. An efficiently applied One Health concept would largely reduce the cost of PEP in resource poor countries and should be implemented for zoonosis control in general.

Keywords: Chad; One Health; cost efficiency; post-exposure prophylaxis; rabies control and prevention.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Distribution of total number of bite cases reported for the 10 different districts of N’Djamena over the whole study period.
Figure 2
Figure 2
Mean number of dog bites inflicted per time period and proportion of vaccination status categories. July to September 2012 corresponds to the pre-vaccination campaign period. June 2012 was excluded due to very low overall number of cases reported.
Figure 3
Figure 3
Number of post-exposure prophylaxis (PEP) recommended per month compared to the number of monthly cases per exposure risk group.
Figure 4
Figure 4
Display of the cost trend of the three different rabies control scenarios.

References

    1. World Health Organization. WHO Expert Consultation on Rabies. Second Report. World Health Organization Technical Report Series. Geneva: WHO; (2013). p. 1–139. - PubMed
    1. Jackson AC. Current and future approaches to the therapy of human rabies. Antiviral Res (2013) 99(1):61–7.10.1016/j.antiviral.201301003 - DOI - PubMed
    1. Hampson K, Coudeville L, Lembo T, Sambo M, Kieffer A, Attlan M, et al. Estimating the global burden of endemic canine rabies. PLoS Negl Trop Dis (2015) 9(4):e0003709.10.1371/journal.pntd.0003709 - DOI - PMC - PubMed
    1. Hampson K, Dushoff J, Cleaveland S, Haydon DT, Kaare M, Packer C, et al. Transmission dynamics and prospects for the elimination of canine rabies. PLoS Biol (2009) 7(3):e53.10.1371/journal.pbio.1000053 - DOI - PMC - PubMed
    1. Rupprecht CE, Hanlon CA, Slate D. Control and prevention of rabies in animals: paradigm shifts. Dev Biol (Basel) (2006) 125:103–11. - PubMed
Cite

AltStyle によって変換されたページ (->オリジナル) /